The indication of a role for the OAS1 enzyme in AD originally came to light through transcriptomic investigations in response to amyloid deposition in microglia from mouse models of AD [9] and subsequently supported by similar observations in iPSC-derived astrocytes from PSEN1-mutation-carrying cell lines [14]. Here, PSEN1 is linked to Alzheimer disease.